Share this video  

ESMO 2020 | ADAURA clinical trial update

Deborah Doroshow, MD, PhD, Mount Sinai Medical Center, New York, NY, discusses results from the ADAURA (NCT02511106) clinical trial, which demonstrated a significant decrease in brain metastases with adjuvant osimertinib versus a placebo. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter